Citations

Showing 10 of 108094 citations.

Recurrent benign lymphocytic (Mollaret’s) meningitis due to herpes simplex virus type 2
Grinney, Michael, Mohseni, Michael , Mohseni, Michael M

Mayo Clinic

Baylor University Medical Center Proceedings | August 11, 2022 | Volume: 35 | Issue: 6 | Pages: 820-821

10.1080/08998280.2022.2108991 | PMID 36304598 Get It

Better Left Aloe? Contact Allergens in Aloe Vera Gels
Xiong, Michelle , Ekstein, Samuel F. , Neeley, Anne

Mayo Clinic

Dermatitis® | August 11, 2022 | Volume: 34 | Issue: 3 | Pages: 258-259

10.1097/der.0000000000000933 | PMID 35951424 Get It

Nationwide Clinical Practice Patterns of Anesthesiology Critical Care Physicians: A Survey to Members of the Society of Critical Care Anesthesiologists
Shaefi, Shahzad , Pannu, Ameeka, Mueller, Ariel , Flynn, Brigid C. , Evans, Adam S., Jabaley, Craig S. , Siddiqui, Shahla , Boone, Mathieu , Monteith, Erika, Abalama, Vivian, Nunnally, Mark , Cobas, Miguel , Jabaley, Craig S , Mladinov, Domagoj , Wall, Michael , Douin, David J. , Boone, M. Dustin, Warner, Matthew A. , Stevens, Robert David , Siddiqui, Shahla

Mayo Clinic

Anesthesia & Analgesia | August 11, 2022 | Volume: 136 | Issue: 2 | Pages: 295-307

10.1213/ane.0000000000006160 | PMID 35950751 Get It

BACKGROUND: Despite the growing contributions of critical care anesthesiologists to clinical practice, research, and administrative leadership of intensive care units (ICUs), relatively little is known about the subspecialty-specific clinical practice environment. An understanding of contemporary clinical practice is essential to recognize the opportunities and challenges facing critical care anesthesia, optimize staffing patterns, assess sustainability and satisfaction, and strategically plan for future activity, scope, and training. This study surveyed intensivists who are members of the Society of Critical Care Anesthesiologists (SOCCA) to evaluate practice patterns of critical care anesthesiologists, including compensation, types of ICUs covered, models of overnight ICU coverage, and relationships between these factors. We hypothesized that variability in compensation and practice patterns would be observed between individuals. METHODS: Board-certified critical care anesthesiologists practicing in the United States were identified using the SOCCA membership distribution list and invited to take a voluntary online survey between May and June 2021. Multiple-choice questions with both single- and multiple-select options were used for answers with categorical data, and adaptive questioning was used to clarify stem-based responses. Respondents were asked to describe practice patterns at their respective institutions and provide information about their demographics, salaries, effort in ICUs, as well as other activities. RESULTS: A total of 490 participants were invited to take this survey, and 157 (response rate 32%) surveys were completed and analyzed. The majority of respondents were White (73%), male (69%), and younger than 50 years of age (82%). The cardiothoracic/cardiovascular ICU was the most common practice setting, with 69.5% of respondents reporting time working in this unit. Significant variability was observed in ICU practice patterns. Respondents reported spending an equal proportion of their time in clinical practice in the operating rooms and ICUs (median, 40%; interquartile range [IQR], 20%–50%), whereas a smaller proportion—primarily those who completed their training before 2009—reported administrative or research activities. Female respondents reported salaries that were $36,739 less than male respondents; however, this difference was not statistically different, and after adjusting for age and practice type, these differences were less pronounced (–$27,479.79; 95% confidence interval [CI], –$57,232.61 to $2273.03; P = .07). CONCLUSIONS: These survey data provide a current snapshot of anesthesiology critical care clinical practice patterns in the United States. Our findings may inform decision-making around the initiation and expansion of critical care services and optimal staffing patterns, as well as provide a basis for further work that focuses on intensivist satisfaction and burnout.
B307 The effect of acetaminophen and total knee arthroplasty on endogenous plasma endocannabinoid levels
Clendenen, Steven R. , Mcclain, R, Clendenen, N, McClain, Robert L., Clendenen, Nathan

Mayo Clinic

Postoperative pain management | August 11, 2022 | Volume: No volume available | Issue: No issue available | Pages: A228.2-A228

10.1136/rapm-2022-esra.381 Get It

B66 Postoperative analgesia for a chronic pain patient following middle finger fusion with a distal median nerve catheter
Clendenen, Steven R. , Aziz, Keith T.

Mayo Clinic

Peripheral nerve blocks | August 11, 2022 | Volume: No volume available | Issue: No issue available | Pages: A117.2-A118

10.1136/rapm-2022-esra.141 Get It

Development of cutaneous T‐cell lymphoma following exposure to biologic therapy: a Mayo Clinic retrospective analysis
Schaefer, Lauren , Comfere, Nneka I. , Sokumbi, Olayemi , Sokumbi, Olayemi

Mayo Clinic

International Journal of Dermatology | August 11, 2022 | Volume: 62 | Issue: 7 | Pages: No page available

10.1111/ijd.16386 | PMID 35950217 Get It

Assessing perceptions of severity and willingness to seek dermatologic care for common benign and malignant skin conditions based on lesion appearance
Bray, Jeremy K. , Hrin, Matthew L. , Ahn, Christine , Hrin, Matthew L , Purvis, Caitlin G. , Feldman, Steven R.

Mayo Clinic

International Journal of Dermatology | August 11, 2022 | Volume: 62 | Issue: 6 | Pages: No page available

10.1111/ijd.16390 | PMID 35949034 Get It

A phase II trial of regorafenib in patients with advanced Ewing sarcoma and related tumors of soft tissue and bone: SARC024 trial results
Attia, Steven , Ganjoo, Kristen N. , Agulnik, Mark , Rushing, Daniel A., Livingston, Michael B. , Wright, Jennifer , Chawla, Sant P. , Okuno, Scott H. , Riedel, Richard F. , Ryan, Christopher W. , Maki, Robert G. , Reinke, Denise , Davis, Lara E , Maki, Robert G , Riedel, Richard F , Bolejack, Vanessa , George, Suzanne , Loggers, Elizabeth T , Reinke, Denise K. , Davis, Lara E.

Mayo Clinic

Cancer Medicine | August 11, 2022 | Volume: 12 | Issue: 2 | Pages: 1532-1539

10.1002/cam4.5044 | PMID 35950293 Get It

Abstract Background Regorafenib is one of several FDA‐approved cancer therapies targeting multiple tyrosine kinases. However, there are few subtype‐specific data regarding kinase inhibitor activity in sarcomas. We report results of a single arm, phase II trial of regorafenib in advanced Ewing family sarcomas. Methods Patients with metastatic Ewing family sarcomas (age ≥ 18, ECOG 0–2, good organ function) who had received at least one line of therapy and experienced progression within 6 months of registration were eligible. Prior kinase inhibitors were not allowed. The initial dose of regorafenib was 160 mg oral days 1–21 of a 28‐day cycle. The primary endpoint was estimating progression‐free rate (PFR) at 8 weeks employing RECIST 1.1. Results Thirty patients (median age, 32 years; 33% women [10 patients]; bone primary, 40%; extraskeletal primary, 60%) enrolled at 14 sites. The most common grade 3 or higher toxicities were hypophosphatemia (5 grade 3, 1 grade 4), hypertension (2 grade 3), elevated ALT (2 grade 3). Sixteen patients required dose reductions, most often for hypophosphatemia ( n = 7 reductions in 6 patients); two stopped regorafenib for toxicity. There was one death unrelated to treatment in the 30‐day post‐study period. Median progression‐free survival (PFS) was 14.8 weeks (95% CI 7.3–15.9); PFR at 8 weeks by Kaplan–Meier analysis was 63% (95% CI 46–81%). The RECIST 1.1 response rate was 10%. Median OS was 53 weeks (95% CI 37–106 weeks). Conclusions Regorafenib has modest activity in the Ewing family sarcomas. Toxicity was similar to that seen in approval studies.
Bayesian sparse modeling to identify high‐risk subgroups in meta‐analysis of safety data
Qi, Xinyue , Wang, Yucai , Peterson, Christine B. , Zhou, Shouhao , Wang, Yucai , Peterson, Christine , Zhou, Shouhao

Mayo Clinic

Research Synthesis Methods | August 11, 2022 | Volume: 13 | Issue: 6 | Pages: 807-820

10.1002/jrsm.1597 | PMID 36054779 Get It

AbstractMeta‐analysis allows researchers to combine evidence from multiple studies, making it a powerful tool for synthesizing information on the safety profiles of new medical interventions. There is a critical need to identify subgroups at high risk of experiencing treatment‐related toxicities. However, this remains quite challenging from a statistical perspective as there are a variety of clinical risk factors that may be relevant for different types of adverse events, and adverse events of interest may be rare or incompletely reported. We frame this challenge as a variable selection problem and propose a Bayesian hierarchical model which incorporates a horseshoe prior on the interaction terms to identify high‐risk groups. Our proposed model is motivated by a meta‐analysis of adverse events in cancer immunotherapy, and our results uncover key factors driving the risk of specific types of treatment‐related adverse events.
Complications, Symptoms, Presurgical Predictors in Patients With Chronic Hypoparathyroidism: A Systematic Review
Yao, Liang , Xu, Hui , Li, Meixuan , Li, Jing , Ahmed, Muhammad Muneeb , Lin, Clement , Kandi, Maryam , Sreekanta, Ashwini , Makhdami, Nima , Tamilselvan, Divyalakshmi , Ali, Dalal S. , Dandurand, Karel , Yang, Kehu , Bilezikian, John P. , Mannstadt, Michael , Khan, Aliya , Hui, Xu , Tamilselvan, Divya , Brandi, Maria Luisa , Clarke, Bart L , Mannstadt, Michael , Rejnmark, Lars , Khan, Aliya A , Guyatt, Gordon , Brandi, Maria Luisa , Clarke, B.L. , Rejnmark, Lars , Guyatt, Gordon

Mayo Clinic

Journal of Bone and Mineral Research | August 11, 2022 | Volume: 37 | Issue: 12 | Pages: 2642-2653

10.1002/jbmr.4673 | PMID 36375810 Get It

ABSTRACT The complications and symptoms of hypoparathyroidism remain incompletely defined. Measuring serum parathyroid hormone (PTH) and calcium levels early after total thyroidectomy may predict the development of chronic hypoparathyroidism. The study aimed (i) to identify symptoms and complications associated with chronic hypoparathyroidism and determine the prevalence of those symptoms and complications (Part I), and (ii) to examine the utility of early postoperative measurements of PTH and calcium in predicting chronic hypoparathyroidism (Part II). We searched Medline, Medline In-Process, EMBASE, and Cochrane CENTRAL to identify complications and symptoms associated with chronic hypoparathyroidism. We used two predefined criteria (at least three studies reported the complication and symptom and had statistically significantly greater pooled relative estimates). To estimate prevalence, we used the median and interquartile range (IQR) of the studies reporting complications and symptoms. For testing the predictive values of early postoperative measurements of PTH and calcium, we used a bivariate model to perform diagnostic test meta-analysis. In Part I, the 93 eligible studies enrolled a total of 18,973 patients and reported on 170 complications and symptoms. We identified nine most common complications or symptoms probably associated with chronic hypoparathyroidism. The complications or symptoms and the prevalence are as follows: nephrocalcinosis/nephrolithiasis (median prevalence among all studies 15%), renal insufficiency (12%), cataract (17%), seizures (11%), arrhythmia (7%), ischemic heart disease (7%), depression (9%), infection (11%), and all-cause mortality (6%). In Part II, 18 studies with 4325 patients proved eligible. For PTH measurement, regarding the posttest probability, PTH values above 10 pg/mL 12–24 hours postsurgery virtually exclude chronic hypoparathyroidism irrespective of pretest probability (100%). When PTH values are below 10 pg/mL, posttest probabilities range from 3% to 64%. Nine complications and symptoms are probably associated with chronic hypoparathyroidism. A PTH value above a threshold of 10 pg/mL 12–24 hours after total thyroidectomy is a strong predictor that the patients will not develop chronic hypoparathyroidism. Patients with PTH values below the threshold need careful monitoring as some will develop chronic hypoparathyroidism. © 2022 The Authors. Journal of Bone and Mineral Research published by Wiley Periodicals LLC on behalf of American Society for Bone and Mineral Research (ASBMR).